In This Section      

Executive Women's Breakfast 2019 Speaker Profiles

Stephen Baylin, M.D.
Meg Gerstenblith, M.D.
Rebecca Gottesman, M.D., Ph.D.


Stephen Baylin, M.D.
Stephen B. Baylin, M.D.
Virginia and D.K. Ludwig Professor for Cancer Research Professor of Oncology and Medicine
Co-Director, Cancer Biology Division
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


Stephen B. Baylin, M.D., is Virginia and D.K. Ludwig Professor of Oncology and Medicine, and Co-Director of the Cancer Biology Division at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. 

His research interests include cellular biology and genetics of cancer, specifically epigenetics or genetic modifications other than those in DNA that can affect cell behavior, and silencing of tumor suppressor genes and tumor progression. His research has looked at the mechanisms through which variations in tumor cells derive, and cell differentiation in cancers such as medullary thyroid carcinoma and small cell lung carcinoma.

Dr. Baylin’s honors include the 2004 National Investigator of the Year Award from the NCI SPORE program; the 2005 Jack Gibson Visiting Professorship, University of Hong Kong Queen Mary Hospital, Hong Kong; the 2005 Shubitz Cancer Research Prize from the University of Chicago; the 2008 Raffaele Tecce Memorial Lecture, Rome, Italy; the 2008 David Workman Memorial Award from the Waxman Foundation; the 2009 Kirk A. Landon-AACR Prize for Basic and Translational Cancer Research (jointly with Peter A. Jones, Ph.D.); the 2010 14th NCI Alfred G. Knudson Award in Cancer Genetics and the 2011 American Cancer  Society’s Medal of Honor Award (jointly with Peter A. Jones, Ph.D.) and most recently the Fellows of The American Association of Cancer Research  – Academy Class of 2014. 

Dr. Baylin has served on the American Association for Cancer Research Board of Directors from 2004 through 2007, and is an associate editor of Cancer Research. He has also presented frequently at AACR conferences and chaired the special conference on “DNA Methylation, Imprinting and the Epigenetics of Cancer.” Dr. Baylin has authored or co-authored more than 400 publications.

In 2017, Dr. Baylin was elected to the Association of American Physicians as well as the National Academy of Science.

Dr. Baylin attended Duke University, where he earned his medical degree in 1968 and completed his internship and first year residency in internal medicine. He then worked for two years at the National Heart and Lung Institute of the National Institutes of Health (NIH). In 1971, Dr. Baylin joined the departments of oncology and medicine at Johns Hopkins University School of Medicine.



Meg Gerstenblith, M.D.
Meg Gerstenblith, M.D.
Clinical Associate of Dermatology

Meg Gerstenblith, M.D. is a clinical associate in Dermatology at Johns Hopkins. 

Her focus is on general dermatology and melanoma.

She has co-written over 35 peer reviewed articles and over 40 abstracts on the topics of dermatology and cutaneous oncology.

She received her medical degree from the Johns Hopkins University School of Medicine where she also completed her Dermatology residency.







Rebecca Gottesman
Rebecca Gottesman, M.D., Ph.D.
Professor of Neurology

Rebecca Gottesman, M.D., Ph.D. is a Professor of Neurology, with a joint appointment in Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and is a core faculty member of the Welch Center for Prevention, Epidemiology, and Clinical Research. Her primary clinical interest is stroke.

Her primary research interests include the vascular contribution to cognitive impairment and dementia, with evaluation not only of stroke as a potential risk factor for cognitive change but also vascular risk factors such as hypertension. She works primarily with the Atherosclerosis Risk in Communities (ARIC) study in order to evaluate these long-term associations between vascular risk factors and vascular disease, each, and cognition, using epidemiology and neuroimaging methods. She runs the SCAN lab (Stroke and Cognitive impairment Analysis using Neuroepidemiology) to pursue these research interests.

Dr. Gottesman received her medical degree from the Columbia College of Physicians and Surgeons in New York.  She completed her internship in internal medicine at the Johns Hopkins Bayview Medical Center, and her neurology residency and stroke fellowship at the Johns Hopkins Hospital in Baltimore, Maryland. She received a PhD in the Graduate Training Program in Clinical Investigation (GTPCI) from the Johns Hopkins Bloomberg School of Public Health.